SHANICE WATTS: Open Payments
NPI 1952924631 · GILROY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,393 in 101 payments from 20 companies in 2025. Trend: 2023 $3,048 · 2024 $2,097 · 2025 $2,393
Food & beverage: $2,284Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $341 |
| LEO Pharma Inc. | 5 | $269 |
| UCB, Inc. | 12 | $264 |
| GENZYME CORPORATION | 6 | $210 |
| Janssen Biotech, Inc. | 7 | $199 |
| Galderma Laboratories, L.P. | 3 | $184 |
| Regeneron Healthcare Solutions, Inc. | 6 | $183 |
| Incyte Corporation | 11 | $166 |
| Arcutis Biotherapeutics, Inc. | 5 | $102 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
Products named: SKYRIZI, DUPIXENT, ADBRY, Bimzelx, TREMFYA, NEMLUVIO, OPZELURA, Zoryve.
Industry payments across CA — which companies pay providers there.
